These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5407741)

  • 1. Laboratory studies on the rimino-phenazines.
    Byrne J; Conalty ML; Jina A
    Tubercle; 1969 Mar; 50():Suppl:22-8. PubMed ID: 5407741
    [No Abstract]   [Full Text] [Related]  

  • 2. The antileprosy agent B.663 (Clofazimine) and the reticuloendothelial system.
    Conalty ML; Barry VC; Jina A
    Int J Lepr Other Mycobact Dis; 1971; 39(2):479-92. PubMed ID: 4948088
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental chemotherapy of mycobacterioses provoked by atypical mycobacteria.
    Burjanová B; Urbancik R
    Bibl Tuberc; 1970; 26():154-88. PubMed ID: 4983240
    [No Abstract]   [Full Text] [Related]  

  • 4. The failure of the rimino phenazine B663 (G30320) to reduce the level of experimental Mycobacterium johnei infections in calves.
    Gilmour NJ
    Br Vet J; 1970 Mar; 126(3):v-vi. PubMed ID: 5440612
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of the rimino phenazine B663 (G30320) on Mycobacterium johnei infection and reinfection in sheep. II. Pathology.
    Angus KW; Gilmour NJ
    J Comp Pathol; 1971 Apr; 81(2):227-34. PubMed ID: 5091663
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of the rimino phenazine B663 (G30320) on Mycobacterium johnei infection and reinfection in sheep. I. Bacteriology and hypersensitivity.
    Gilmour NJ; Angus KW
    J Comp Pathol; 1971 Apr; 81(2):221-6. PubMed ID: 5091662
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
    Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
    Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycobacteria of surgical interest.
    Karlson AG
    Surg Clin North Am; 1973 Aug; 53(4):905-12. PubMed ID: 4197849
    [No Abstract]   [Full Text] [Related]  

  • 9. Storage of rimino compound B. 663 in tumor-free and tumor-bearing mice.
    Stern K
    J Reticuloendothel Soc; 1969 Feb; 6(1):24-33. PubMed ID: 5766370
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro and in vivo antimycobacterial activity of antiinflammatory drug, diclofenac sodium.
    Dutta NK; Kumar KA; Mazumdar K; Dastidar SG
    Indian J Exp Biol; 2004 Sep; 42(9):922-7. PubMed ID: 15462188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro and in vivo antimycobacterial activities of cefpimizole (AC-1370) and its effect on oxygen metabolism of host macrophages].
    Sato K; Saito H; Tomioka H
    Kekkaku; 1988 Jan; 63(1):19-25. PubMed ID: 3361739
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycobacterium ulcerans infection. Clinical and bacteriological study of the first cases recognized in South East Asia.
    Pettit JH; Marchette NJ; Rees RJ
    Br J Dermatol; 1966 Apr; 78(4):187-97. PubMed ID: 5910904
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis.
    Sanguinetti M; Ardito F; Fiscarelli E; La Sorda M; D'Argenio P; Ricciotti G; Fadda G
    J Clin Microbiol; 2001 Feb; 39(2):816-9. PubMed ID: 11158161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis.
    De Logu A; Palchykovska LH; Kostina VH; Sanna A; Meleddu R; Chisu L; Alexeeva IV; Shved AD
    Int J Antimicrob Agents; 2009 Mar; 33(3):223-9. PubMed ID: 19070992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampicin in experimental Mycobacterium ulcerans infection.
    Stanford JL; Phillips I
    J Med Microbiol; 1972 Feb; 5(1):39-45. PubMed ID: 5022508
    [No Abstract]   [Full Text] [Related]  

  • 16. [The Buruli ulcer].
    Kieninger G; Schubert GE; Ullmann U
    Z Tropenmed Parasitol; 1972 Dec; 23(4):342-53. PubMed ID: 4650088
    [No Abstract]   [Full Text] [Related]  

  • 17. B 663 (Lampren) in mycobacterial infections.
    Pettit JH
    Br J Dermatol; 1969 Oct; 81(10):794-5. PubMed ID: 5379868
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimycobacterial effect of cycloserine.
    Lucchesi M
    Scand J Respir Dis Suppl; 1970; 71():13-21. PubMed ID: 5317743
    [No Abstract]   [Full Text] [Related]  

  • 19. Establishment of an in vitro model using NR8383 cells and Mycobacterium bovis Calmette-Guerin that mimics a chronic infection of Mycobacterium tuberculosis.
    Hino M; Oda M; Yoshida A; Nakata K; Kohchi C; Nishizawa T; Inagawa H; Hori H; Makino K; Terada H; Soma G
    In Vivo; 2005; 19(5):821-30. PubMed ID: 16097433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B663 in treatment of atypical tuberculous disease.
    Heyworth F
    Med J Aust; 1967 Jan; 1(3):106-7. PubMed ID: 6018438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.